Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cohort studies investigating aging and dementia require APOE genotyping. We compared directly measured APOE genotypes to 'hard-call' genotypes derived from imputing genome-wide genotyping data from a range of platforms using several imputation panels. Older GWAS arrays imputed to 1000 Genomes Project (1KGP) phases and the Haplotype Reference Consortium (HRC) reference panels were able to achieve concordance rates of over 98% with stringent quality control (hard-call-threshold 0.8). However, this resulted in high levels of missingness (>12% with 1KGP and 5% with HRC). With recent GWAS arrays, concordance of 99% could be obtained with relatively lenient QC, resulting in no missingness.

Original publication

DOI

10.3233/JAD-171104

Type

Journal article

Journal

J Alzheimers Dis

Publication Date

2018

Volume

64

Pages

49 - 54

Keywords

Alzheimer’s disease, ApoE receptor, cohort studies, computational biology, genetic association studies, Alzheimer Disease, Apolipoproteins E, Cohort Studies, Female, Gene Frequency, Genome-Wide Association Study, Genotype, Humans, Male, Polymorphism, Single Nucleotide